SXTC revokes Alpha Vantage · The Manila Times · · AI-summarised by FinFlash
China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) terminated the additional purchase right granted to purchasers in its registered direct offering from October 8, 2026. The right had allowed buyers to acquire up to an additional Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · The Manila Times · · AI-summarised by FinFlash
China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) terminated the additional purchase right granted to purchasers in its registered direct offering from October 8, 2026. The right had allowed buyers to acquire up to an additional Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context